Loading...
Loading...
India's mesalamine imports from TAIWAN total $153 across 1 shipments from 1 foreign suppliers. SUNNY PHARMTECH INC. leads with $153 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ENEM NOSTRUM REMEDIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for mesalamine โ a concentrated sourcing relationship with select suppliers from TAIWAN.

SUNNY PHARMTECH INC. is the leading Mesalamine supplier from TAIWAN to India, with import value of $153 across 1 shipments. The top 5 suppliers โ SUNNY PHARMTECH INC. โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SUNNY PHARMTECH INC. | $153 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ENEM NOSTRUM REMEDIES PRIVATE LIMITED | $153 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Mesalamine suppliers from TAIWAN to India include SUNNY PHARMTECH INC.. The leading supplier is SUNNY PHARMTECH INC. with import value of $153 USD across 1 shipments. India imported Mesalamine worth $153 USD from TAIWAN in total across 1 shipments.
India imported Mesalamine worth $153 USD from TAIWAN across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Mesalamine sourced from TAIWAN include ENEM NOSTRUM REMEDIES PRIVATE LIMITED. The largest buyer is ENEM NOSTRUM REMEDIES PRIVATE LIMITED with $153 in imports across 1 shipments.
The total value of Mesalamine imports from TAIWAN to India is $153 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists